Obesity-metabolic derangement exacerbates cardiomyocyte loss distal to moderate coronary artery stenosis in pigs without affecting global cardiac function

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 306, Issue 7, 2014, Pages

  Li, Zi Lun ^a,b   Ebrahimi, Behzad ^a   Zhang, Xin ^a   Eirin, Alfonso ^a   Woollard, John R ^a   Tang, Hui ^a   Lerman, Amir ^a   Wang, Shen Ming ^b   Lerman, Lilach O ^a  

^a MAYO CLINIC   (United States)

^b SUN YAT SEN UNIVERSITY   (China)

Author keywords

Apoptosis; Autophagy; Inflammation

Indexed keywords

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; ATHEROGENIC DIET; CONTROLLED STUDY; CORONARY ARTERY CIRCUMFLEX BRANCH; CORONARY ARTERY OBSTRUCTION; DISEASE EXACERBATION; DOWN REGULATION; DYSLIPIDEMIA; HEART FUNCTION; HEART MUSCLE CELL; HEART MUSCLE FIBROSIS; HEART MUSCLE PERFUSION; HISTOLOGY; IMMUNOBLOTTING; INSULIN RESISTANCE; MACROPHAGE; METABOLIC DISORDER; MICRO-COMPUTED TOMOGRAPHY; MICROCIRCULATION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SCANNER; OBESITY; OBESITY ASSOCIATED WITH METABOLIC DERANGEMENT; OXIDATIVE STRESS; OXYGENATION; PRIORITY JOURNAL; PROGNOSIS; SHAM PROCEDURE; SUSCEPTIBILITY WEIGHTED IMAGING; SWINE;

APOPTOSIS; AUTOPHAGY; INFLAMMATION;

ADIPOSITY; ANIMALS; APOPTOSIS; AUTOPHAGY; CORONARY CIRCULATION; CORONARY STENOSIS; DISEASE MODELS, ANIMAL; ENERGY METABOLISM; FIBROSIS; HEMODYNAMICS; HYPERLIPIDEMIAS; INFLAMMATION MEDIATORS; INSULIN RESISTANCE; METABOLIC SYNDROME X; MICROCIRCULATION; MYOCYTES, CARDIAC; NEOVASCULARIZATION, PHYSIOLOGIC; OBESITY; OXIDATIVE STRESS; OXYGEN CONSUMPTION; SWINE; TIME FACTORS;

EID: 84900533598     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00052.2013     Document Type: Article

References (44)

1. Baldi A, Abbate A, Bussani R, Patti G, Melfi R, Angelini A, Dobrina A, Rossiello R, Silvestri F, Baldi F, Di Sciascio G. Apoptosis and post-infarction left ventricular remodeling. J Mol Cell Cardiol 34: 165-174, 2002.
2. Bender SB, Tune JD, Borbouse L, Long X, Sturek M, Laughlin MH. Altered mechanism of adenosine-induced coronary arteriolar dilation in early-stage metabolic syndrome. Exp Biol Med (Maywood) 234: 683-692, 2009.
3. + channels to metabolic control of coronary blood flow. J Mol Cell Cardiol 52: 912-919, 2012.
4. Bugger H, Abel ED. Molecular mechanisms for myocardial mitochondrial dysfunction in the metabolic syndrome. Clin Sci (Lond) 114: 195-210, 2008.
5. Bugiardini R, Merz CNB. Angina with "normal" coronary arteries a changing philosophy. JAMA 293: 477-484, 2005.
6. Caceres VHU, Lin J, Zhu XY, Favreau FD, Gibson ME, Crane JA, Lerman A, Lerman LO. Early experimental hypertension preserves the myocardial microvasculature but aggravates cardiac injury distal to chronic coronary artery obstruction. Am J Physiol Heart Circ Physiol 300: H693-H701, 2011.
7. Cerqueira MD, Weissman NJ, Dilsizian V, Jacobs AK, Kaul S, Laskey WK, Pennell DJ, Rumberger JA, Ryan T, Verani MS. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation 105: 539-542, 2002.
8. Daly CA, Hildebrandt P, Bertrand M, Ferrari R, Remme W, Simoons M, Fox KM, Investigators E. Adverse prognosis associated with the metabolic syndrome in established coronary artery disease: data from the EUROPA trial. Heart 93: 1406-1411, 2007.
9. Diano S, Horvath TL. Mitochondrial uncoupling protein 2 (UCP2) in glucose and lipid metabolism. Trends Mol Med 18: 52-58, 2012.
10. Dyson MC, Alloosh M, Vuchetich JP, Mokelke EA, Sturek M. Components of metabolic syndrome and coronary artery disease in female ossabaw swine fed excess atherogenic diet. Comp Med 56: 35-45, 2006.
11. Ervin RB. Prevalence of metabolic syndrome among adults 20 years of age and over, by sex, age, race and ethnicity, and body mass index: United States, 2003-2006. Natl Health Stat Report 13: 1-7, 2009.
12. Galili O, Versari D, Sattler KJ, Olson ML, Mannheim D, McConnell JP, Chade AR, Lerman LO, Lerman A. Early experimental obesity is associated with coronary endothelial dysfunction and oxidative stress. Am J Physiol Heart Circ Physiol 292: H904-H911, 2007.
13. Glazer HP, Osipov RM, Clements RT, Sellke FW, Bianchi C. Hypercholesterolemia is associated with hyperactive cardiac mTORC1 and mTORC2 signaling. Cell Cycle 8: 1738-1746, 2009.
14. Gobel FL, Norstrom LA, Nelson RR, Jorgensen CR, Wang Y. The rate-pressure product as an index of myocardial oxygen consumption during exercise in patients with angina pectoris. Circ Res 57: 549-556, 1978.
15. Gonzalez CD, Lee MS, Marchetti P, Pietropaolo M, Towns R, Vaccaro MI, Watada H, Wiley JW. The emerging role of autophagy in the pathophysiology of diabetes mellitus. Autophagy 7: 2-11, 2011.
16. Harris J, De Haro SA, Master SS, Keane J, Roberts EA, Delgado M, Deretic V. T helper 2 cytokines inhibit autophagic control of intracellular mycobacterium tuberculosis. Immunity 27: 505-517, 2007.
17. Jiang Q, Wang Y, Li T, Shi K, Li Z, Ma Y, Li F, Luo H, Yang Y, Xu C. Heat shock protein 90-mediated inactivation of nuclear factor-kappaB switches autophagy to apoptosis through becn1 transcriptional inhibition in selenite-induced NB4 cells. Mol Biol Cell 22: 1167-1180, 2011.
18. Kelley KW, Curtis SE, Marzan GT, Karara HM, Anderson CR. Body surface area of female swine. J Anim Sci 36: 927-930, 1973.
19. Koga H, Kaushik S, Cuervo AM. Altered lipid content inhibits autophagic vesicular fusion. FASEB J 24: 3052-3065, 2010.
20. Lagouge M, Argmann C, Gerhart-Hines Z, Meziane H, Lerin C, Daussin F, Messadeq N, Milne J, Lambert P, Elliott P, Geny B, Laakso M, Puigserver P, Auwerx J. Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1 alpha. Cell 127: 1109-1122, 2006.
21. Li Z, Woollard JR, Wang S, Korsmo MJ, Ebrahimi B, Grande JP, Textor SC, Lerman A, Lerman LO. Increased glomerular filtration rate in early metabolic syndrome is associated with renal adiposity and microvascular proliferation. Am J Physiol Renal Physiol 301: F1078-F1087, 2011.
22. Li ZL, Woollard JR, Ebrahimi B, Crane JA, Jordan KL, Lerman A, Wang SM, Lerman LO. Transition from obesity to metabolic syndrome is associated with altered myocardial autophagy and apoptosis. Arterioscler Thromb Vasc Biol 32: 1132-1141, 2012.
23. Marroquin OC, Kip KE, Kelley DE, Johnson BD, Shaw LJ, Merz CNB, Sharaf BL, Pepine CJ, Sopko G, Reis SE, Investigators W. Metabolic syndrome modifies the cardiovascular risk associated with angiographic coronary artery disease in women-A report from the Women's Ischemia Syndrome Evaluation. Circulation 109: 714-721, 2004.
24. Min JK, Dunning A, Lin FY, Achenbach S, Al-Mallah M, Budoff MJ, Cademartiri F, Callister TQ, Chang HJ, Cheng V, Chinnaiyan K, Chow BJW, Delago A, Hadamitzky M, Hausleiter J, Kaufmann P, Maffei E, Raff G, Shaw LJ, Villines T, Berman DS, Investigators C. Age-and Sex-Related Differences in All-Cause Mortality Risk Based on Coronary Computed Tomography Angiography Findings Results From the International Multicenter CONFIRM (Coronary CT Angiography Evaluation for Clinical Outcomes: An International Multicenter Registry) of 23,854 Patients Without Known Coronary Artery Disease. J Am Coll Cardiol 58: 849-860, 2011.
25. Nigam A, Bourassa MG, Fortier A, Guertin MC, Tardif JC. The metabolic syndrome and its components and the long-term risk of death in patients with coronary heart disease. Am Heart J 151: 514-520, 2006.
26. Peterson LR, Herrero P, Schechtman KB, Racette SB, Waggoner AD, Kisrieva-Ware Z, Dence C, Klein S, Marsala J, Meyer T, Gropler RJ. Effect of obesity and insulin resistance on myocardial substrate metabolism and efficiency in young women. Circulation 109: 2191-2196, 2004.
27. Rodriguez-Porcel M, Lerman A, Ritman EL, Wilson SH, Best PJM, Lerman LO. Altered myocardial microvascular 3D architecture in experimental hypercholesterolemia. Circulation 102: 2028-2030, 2000.
28. Tamarappoo B, Dey D, Shmilovich H, Nakazato R, Gransar H, Cheng VY, Friedman JD, Hayes SW, Thomson LEJ, Slomka PJ, Rozanski A, Berman DS. Increased pericardial fat volume measured from noncontrast CT predicts myocardial ischemia by SPECT. JACC Cardiovasc Imaging 3: 1104-1112, 2010.
29. Tonino PAL, Fearon WF, De Bruyne B, Oldroyd KG, Leesar MA, Lee PNV, MacCarthy PA, vant Veer M, Pijls NHJ. Angiographic versus functional severity of coronary artery stenoses in the FAME study fractional flow reserve versus angiography in multivessel evaluation. J Am Coll Cardiol 55: 2816-2821, 2010.
30. Urbieta Caceres VH, Lin J, Zhu XY, Favreau FD, Gibson ME, Crane JA, Lerman A, Lerman LO. Early experimental hypertension preserves the myocardial microvasculature but aggravates cardiac injury distal to chronic coronary artery obstruction. Am J Physiol Heart Circ Physiol 300: H693-H701, 2011.
31. Warner L, Glockner JF, Woollard J, Textor SC, Romero JC, Lerman LO. Determinations of renal cortical and medullary oxygenation using blood oxygen level-dependent magnetic resonance imaging and selective diuretics. Invest Radiol 46: 41-47, 2011.
32. Whiteman EL, Cho H, Birnbaum MJ. Role of Akt/protein kinase B in metabolism. Trends Endocrinol Metab 13: 444-451, 2002.
33. Wilson RF, Marcus ML, White CW. Prediction of the physiologic significance of coronary arterial lesions by quantitative lesion geometry in patients with limited coronary artery disease. Circulation 75: 723-732, 1987.
34. Witteles RM, Fowler MB. Insulin-resistant cardiomyopathy. J Am Coll Cardiol 51: 93-102, 2008.
35. Wong ND, Rozanski A, Gransar H, Miranda-Peats R, Kang XP, Hayes S, Shaw L, Friedman J, Polk D, Berman DS. Metabolic syndrome and diabetes are associated with an increased likelihood of inducible myocardial ischemia among patients with subclinical atherosclerosis. Diabetes Care 28: 1445-1450, 2005.
36. Yan L, Vatner DE, Kim SJ, Ge H, Masurekar M, Massover WH, Yang GP, Matsui Y, Sadoshima J, Vatner SF. Autophagy in chronically ischemic myocardium. Proc Natl Acad Sci USA 102: 13807-13812, 2005.
37. Yang L, Li P, Fu SN, Calay ES, Hotamisligil GS. Defective hepatic autophagy in obesity promotes ER stress and causes insulin resistance. Cell Metab 11: 467-478, 2010.
38. Yu CM, Lin H, Yang H, Kong SL, Zhang Q, Lee SWL. Progression of systolic abnormalities in patients with "isolated" diastolic heart failure and diastolic dysfunction. Circulation 105: 1195-1201, 2002.
39. Zhang X, Li ZL, Woollard JR, Eirin A, Ebrahimi B, Crane JA, Zhu XY, Pawar A, Krier JD, Jordan KL, Tang H, Textor SC, Lerman A, Lerman LO. Obesity-metabolic derangement preserves hemodynamics but promotes intra-renal adiposity and macrophage infiltration in swine renovascular disease. Am J Physiol Renal Physiol 305: F265-F276, 2013.
40. Zhou FF, Yang Y, Xing D. Bcl-2 and Bcl-xL play important roles in the crosstalk between autophagy and apoptosis. FEBS J 278: 403-413, 2011.
41. Zhu XY, Daghini E, Chade AR, Napoli C, Ritman EL, Lerman A, Lerman LO. Simvastatin prevents coronary microvascular remodeling in renovascular hypertensive pigs. J Am Soc Nephrol 18: 1209-1217, 2007.
42. Zhu XY, Daghini E, Chade AR, Versari D, Krier JD, Textor KB, Lerman A, Lerman LO. Myocardial microvascular function during acute coronary artery stenosis: effect of hypertension and hypercholesterolaemia. Cardiovasc Res 83: 371-380, 2009.
43. Zhu XY, Rodriguez-Porcel M, Bentley MD, Chade AR, Sica V, Napoli C, Caplice N, Ritman EL, Lerman A, Lerman LO. Antioxidant intervention attenuates myocardial neovascularization in hypercholesterolemia. Circulation 109: 2109-2115, 2004.
44. Zoncu R, Efeyan A, Sabatini DM. mTOR: from growth signal integration to cancer, diabetes and ageing. Nat Rev Mol Cell Biol 12: 21-35, 2011.